John Nuss, Chief Scientific Officer at Ventyx Biosciences ($VTYX), sold shares on the open market twice in the last year, totaling nearly $100,000. His most recent sale occurred on December 18, 2025. These sales rank him 9,591st among 11,678 insiders, far below the average of $8.6 million per seller and 6.4 transactions. Nuss made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 4, 2026 | Ventyx Biosciences, Inc. | $VTYX | Nuss John | CHIEF SCIENTIFIC OFFICER | D | Common Stock | 489481 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.69% |
| March 4, 2026 | Ventyx Biosciences, Inc. | $VTYX | Nuss John | CHIEF SCIENTIFIC OFFICER | D | Stock Option (right to buy) | 108750 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.15% |
| March 4, 2026 | Ventyx Biosciences, Inc. | $VTYX | Nuss John | CHIEF SCIENTIFIC OFFICER | D | Stock Option (right to buy) | 139722 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.20% |
| March 4, 2026 | Ventyx Biosciences, Inc. | $VTYX | Nuss John | CHIEF SCIENTIFIC OFFICER | D | Stock Option (right to buy) | 145000 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.20% |
| March 4, 2026 | Ventyx Biosciences, Inc. | $VTYX | Nuss John | CHIEF SCIENTIFIC OFFICER | D | Stock Option (right to buy) | 192778 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.27% |
| March 4, 2026 | Ventyx Biosciences, Inc. | $VTYX | Nuss John | CHIEF SCIENTIFIC OFFICER | D | Stock Option (right to buy) | 181250 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.25% |
| March 4, 2026 | Ventyx Biosciences, Inc. | $VTYX | Nuss John | CHIEF SCIENTIFIC OFFICER | D | Stock Option (right to buy) | 125000 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.18% |
| March 4, 2026 | Ventyx Biosciences, Inc. | $VTYX | Nuss John | CHIEF SCIENTIFIC OFFICER | D | Stock Option (right to buy) | 415104 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.58% |
| March 4, 2026 | Ventyx Biosciences, Inc. | $VTYX | Nuss John | CHIEF SCIENTIFIC OFFICER | D | Restricted Stock Units | 9063 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.01% |
| Dec. 18, 2025 | Ventyx Biosciences, Inc. | $VTYX | Nuss John | CHIEF SCIENTIFIC OFFICER | S | Common Stock | 12675 | $7.72 | 489,481.0000 | 71,358,638 | 2.52% | 0.02% |
| Dec. 17, 2025 | Ventyx Biosciences, Inc. | $VTYX | Nuss John | CHIEF SCIENTIFIC OFFICER | M | Restricted Stock Units | 34930 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.05% |
| Dec. 17, 2025 | Ventyx Biosciences, Inc. | $VTYX | Nuss John | CHIEF SCIENTIFIC OFFICER | M | Common Stock | 34930 | $0.00 | 502,156.0000 | 71,358,638 | 7.48% | 0.05% |
| April 2, 2025 | Ventyx Biosciences, Inc. | $VTYX | Nuss John | CHIEF SCIENTIFIC OFFICER | S | Common Stock | 1887 | $1.07 | 467,226.0000 | 71,130,054 | 0.40% | 0.00% |
| March 28, 2025 | Ventyx Biosciences, Inc. | $VTYX | Nuss John | CHIEF SCIENTIFIC OFFICER | M | Common Stock | 4531 | $0.00 | 469,113.0000 | 71,130,054 | 0.98% | 0.01% |
| March 28, 2025 | Ventyx Biosciences, Inc. | $VTYX | Nuss John | CHIEF SCIENTIFIC OFFICER | M | Restricted Stock Units | 4531 | $0.00 | 9,063.0000 | 71,130,054 | 33.33% | 0.01% |
| Jan. 2, 2025 | Ventyx Biosciences, Inc. | $VTYX | Nuss John | CHIEF SCIENTIFIC OFFICER | A | Stock Option (Right to Buy) | 245000 | $0.00 | 245,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 2, 2025 | Ventyx Biosciences, Inc. | $VTYX | Nuss John | CHIEF SCIENTIFIC OFFICER | A | Stock Option (right to buy) | 170104 | $0.00 | 170,104.0000 | 0 | 9999.99% | 0.00% |
| Dec. 27, 2024 | Ventyx Biosciences, Inc. | $VTYX | Nuss John | CHIEF SCIENTIFIC OFFICER | S | Common Stock | 21119 | $2.36 | 464,582.0000 | 0 | 4.35% | 0.00% |
| Dec. 17, 2024 | Ventyx Biosciences, Inc. | $VTYX | Nuss John | CHIEF SCIENTIFIC OFFICER | M | Restricted Stock Units | 34930 | $0.00 | 34,930.0000 | 0 | 50.00% | 0.00% |
| Dec. 19, 2024 | Ventyx Biosciences, Inc. | $VTYX | Nuss John | CHIEF SCIENTIFIC OFFICER | S | Common Stock | 13161 | $2.26 | 485,701.0000 | 0 | 2.64% | 0.00% |
| Dec. 17, 2024 | Ventyx Biosciences, Inc. | $VTYX | Nuss John | CHIEF SCIENTIFIC OFFICER | M | Common Stock | 34930 | $0.00 | 498,862.0000 | 0 | 7.53% | 0.00% |
| Dec. 10, 2024 | Ventyx Biosciences, Inc. | $VTYX | Nuss John | CHIEF SCIENTIFIC OFFICER | M | Common Stock | 5377 | $0.20 | 270,375.0000 | 0 | 2.03% | 0.00% |
| Dec. 10, 2024 | Ventyx Biosciences, Inc. | $VTYX | Nuss John | CHIEF SCIENTIFIC OFFICER | M | Stock Option (right to buy) | 5377 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Dec. 10, 2024 | Ventyx Biosciences, Inc. | $VTYX | Nuss John | CHIEF SCIENTIFIC OFFICER | M | Stock Option (Right to Buy) | 193557 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Dec. 10, 2024 | Ventyx Biosciences, Inc. | $VTYX | Nuss John | CHIEF SCIENTIFIC OFFICER | M | Common Stock | 193557 | $0.20 | 463,932.0000 | 0 | 71.59% | 0.00% |
| April 2, 2024 | Ventyx Biosciences, Inc. | $VTYX | Nuss John | CHIEF SCIENTIFIC OFFICER | S | Common Stock | 1651 | $5.40 | 264,998.0000 | 0 | 0.62% | 0.00% |
| March 28, 2024 | Ventyx Biosciences, Inc. | $VTYX | Nuss John | CHIEF SCIENTIFIC OFFICER | M | Restricted Stock Units | 4531 | $0.00 | 13,594.0000 | 0 | 25.00% | 0.00% |
| March 28, 2024 | Ventyx Biosciences, Inc. | $VTYX | Nuss John | CHIEF SCIENTIFIC OFFICER | M | Common Stock | 4531 | $0.00 | 266,649.0000 | 0 | 1.73% | 0.00% |
| Jan. 2, 2024 | Ventyx Biosciences, Inc. | $VTYX | Nuss John | Chief Scientific Officer | A | Stock Option (Right to Buy) | 125000 | $0.00 | 125,000.0000 | 0 | 9999.99% | 0.00% |